Generic construction of single component particles that elicit humoural and cellular immune responses without the need for adjuvants.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 18948160)

Published in Vaccine on October 21, 2008

Authors

P J White1, F Anastasopoulos, J E Church, C-Y Kuo, B J Boyd, P L C Hickey, L Sze Tu, P Burns, A M Lew, W R Heath, G M Davey, C W Pouton

Author Affiliations

1: Medicinal Chemistry and Drug Action, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Australia.

Articles citing this

DEC-205 is a cell surface receptor for CpG oligonucleotides. Proc Natl Acad Sci U S A (2012) 1.29

Articles by these authors

T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66

Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (1998) 11.08

Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol (1998) 11.07

Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72

Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med (1996) 5.21

Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med (1997) 4.01

Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes. J Cell Biol (1986) 3.51

Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol (2001) 3.05

The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J Immunol Methods (1998) 2.78

The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J Immunol (2000) 2.76

CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med (1997) 2.49

Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports. Ann Oncol (2010) 2.46

Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J Immunol (2001) 2.41

Characterization of T cell receptor gamma chain expression in a subset of murine thymocytes. Science (1986) 2.40

Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med (1998) 2.24

Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes (1997) 2.19

Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res (1992) 2.03

Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol Cell Biol (2000) 1.98

The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J Virol (1999) 1.97

An inexpensive alternative to glassmilk for DNA purification. Trends Genet (1995) 1.91

The importance of antibody affinity in the performance of immunoassays for antibody. J Immunol Methods (1985) 1.89

Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol Today (1998) 1.82

High-resolution semi-quantitative real-time PCR without the use of a standard curve. Biotechniques (2001) 1.75

Self-ignorance in the peripheral T-cell pool. Immunol Rev (1993) 1.73

Induction of autoimmune diabetes by oral administration of autoantigen. Science (1996) 1.69

ICRP Publication 111 - Application of the Commission's recommendations to the protection of people living in long-term contaminated areas after a nuclear accident or a radiation emergency. Ann ICRP (2009) 1.63

Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Mol Cell Endocrinol (1997) 1.62

Activation and migration of CD8 T cells in the intestinal mucosa. J Immunol (1997) 1.56

CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc Natl Acad Sci U S A (1999) 1.55

Assessing American Indian families. MCN Am J Matern Child Nurs (1997) 1.55

Thy-1+ dendritic epidermal cells express T3 antigen and the T-cell receptor gamma chain. Proc Natl Acad Sci U S A (1987) 1.48

The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med (1998) 1.47

Ontogeny of T cell tolerance to peripherally expressed antigens. Proc Natl Acad Sci U S A (1999) 1.43

Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature (1998) 1.41

Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur J Immunol (1995) 1.40

Secretion of a soluble class I molecule encoded by the Q10 gene of the C57BL/10 mouse. EMBO J (1985) 1.40

FoLT PCR: a simple PCR protocol for amplifying DNA directly from whole blood. Biotechniques (1993) 1.38

Aortic valve replacement with and without coronary artery bypass graft surgery in octogenarians: is it safe and feasible? Cardiology (2013) 1.38

Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. Int J Cancer (1993) 1.36

Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response. J Exp Med (1989) 1.35

Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int Immunol (1997) 1.33

Structure of the apical membrane antigen I (AMA-1) of Plasmodium chabaudi. Mol Biochem Parasitol (1989) 1.32

Mouse loci for malaria-induced mortality and the control of parasitaemia. Nat Genet (1997) 1.29

Thymus-dependent and thymus-independent developmental pathways for peripheral T cell receptor-gamma delta-bearing lymphocytes. J Immunol (1988) 1.29

Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol Med (1995) 1.28

The measurement of antibody affinity: a comparison of five techniques utilizing a panel of monoclonal anti-DNP antibodies and the effect of high affinity antibody on the measurement of low affinity antibody. J Immunol Methods (1983) 1.28

DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity. Proc Natl Acad Sci U S A (1997) 1.27

BAC-VAC, a novel generation of (DNA) vaccines: A bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1. Proc Natl Acad Sci U S A (1999) 1.26

Is IgG2a a good Th1 marker in mice? Immunol Today (1998) 1.26

The effect of epitope density and antibody affinity on the ELISA as analysed by monoclonal antibodies. J Immunol Methods (1984) 1.25

Predominant transgene expression in exocrine pancreas directed by the CMV promoter. DNA Cell Biol (2000) 1.25

Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells. Nature (1999) 1.23

Interaction of circulating hormones with the brain: the roles of the subfornical organ and the organum vasculosum of the lamina terminalis. Clin Exp Pharmacol Physiol Suppl (1998) 1.20

B cells directly tolerize CD8(+) T cells. J Exp Med (1998) 1.20

SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation. Tissue Antigens (2006) 1.20

Five groups of antigenic determinants on DNA identified by monoclonal antibodies from (NZB X NZW)F1 and MRL/Mp-lpr/lpr mice. Immunology (1985) 1.20

Mapping the platelet profile for functional genomic studies and demonstration of the effect size of the GP6 locus. J Thromb Haemost (2007) 1.18

Antigen-specific CD8+ T cell subset distribution in lymph nodes draining the site of herpes simplex virus infection. Eur J Immunol (1997) 1.18

Antifolate drug selection results in duplication and rearrangement of chromosome 7 in Plasmodium chabaudi. Mol Cell Biol (1989) 1.16

Tetraspanins in viral infections: a fundamental role in viral biology? J Virol (2005) 1.16

Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens. Immunol Rev (1998) 1.10

Immunity or tolerance? That is the question for dendritic cells. Nat Immunol (2001) 1.09

Peptide antagonists that promote positive selection are inefficient at T cell activation and thymocyte deletion. Eur J Immunol (1994) 1.08

Herpes simplex virus type 1-specific cytotoxic T-lymphocyte arming occurs within lymph nodes draining the site of cutaneous infection. J Virol (2000) 1.07

Molecular cloning of a C-type lectin superfamily protein differentially expressed by CD8alpha(-) splenic dendritic cells. Mol Immunol (2001) 1.06

An analysis of late deaths after liver transplantation. Transplantation (1996) 1.06

Class I genes and molecules: an update. Immunology (1986) 1.05

Influence of antibody affinity on the performance of different antibody assays. J Immunol Methods (1984) 1.03

A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge. Proc Natl Acad Sci U S A (2000) 1.02

An fMRI study of stimulus equivalence. Neuroreport (2001) 1.01

A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells. J Immunol (2000) 1.01

A key role for ICAM-1 in generating effector cells mediating inflammatory responses. Nat Immunol (2001) 1.01

Telehealth or telehype? Some observations and thoughts on the current status and future of telehealth. J Healthc Inf Manag (1999) 1.01

Glomerulonephritis induced by pre-formed immune complexes containing monoclonal antibodies of defined affinity and isotype. Clin Exp Immunol (1984) 1.00

Failure of a protective major histocompatibility complex class II molecule to delete autoreactive T cells in autoimmune diabetes. Proc Natl Acad Sci U S A (1993) 1.00

Alternative protein products with different carboxyl termini from a single class I gene, H-2Kb. Proc Natl Acad Sci U S A (1986) 1.00

Characteristics of the expression of the murine soluble class I molecule (Q10). J Immunol (1986) 0.99

The biosynthesis and assembly of T cell receptor alpha- and beta-chains with the CD3 complex. J Immunol (1988) 0.99

Lymphatic malformations: a proposed management algorithm. Int J Pediatr Otorhinolaryngol (2010) 0.98

CD4 help-independent induction of cytotoxic CD8 cells to allogeneic P815 tumor cells is absolutely dependent on costimulation. J Immunol (2000) 0.97

Circulating relaxin acts on subfornical organ neurons to stimulate water drinking in the rat. Proc Natl Acad Sci U S A (2002) 0.97

Transgenic overexpression of human Bcl-2 in islet beta cells inhibits apoptosis but does not prevent autoimmune destruction. Int Immunol (2000) 0.97

Electrical and neurotransmitter activity of mature neurons derived from mouse embryonic stem cells by Sox-1 lineage selection and directed differentiation. Eur J Neurosci (2004) 0.97

Color Doppler artifact in anechoic regions. J Ultrasound Med (1990) 0.96

The effects of acute smoking on platelet behaviour, fibrinolysis and haemorheology in habitual smokers. Thromb Haemost (1984) 0.96

Consequences of self-presentation of peptide antigen by cytolytic T lymphocytes. J Immunol (1989) 0.96

Diminished secondary CTL response in draining lymph nodes on cutaneous challenge with herpes simplex virus. J Gen Virol (2000) 0.96

Phase I chemotherapy study of biochemical modulation of folinic acid and fluorouracil by gemcitabine in patients with solid tumor malignancies. J Clin Oncol (2000) 0.96

The threshold for autoimmune T cell killing is influenced by B7-1. Eur J Immunol (1998) 0.95

Deletion of high-avidity T cells by thymic epithelium. Proc Natl Acad Sci U S A (1995) 0.95

Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab (1993) 0.95

Mucosal antigen primes diabetogenic cytotoxic T-lymphocytes regardless of dose or delivery route. Diabetes (2001) 0.94

Prevention trial in the Cherokee Nation: design of a randomized community trial. Prev Sci (2015) 0.94

Isolation of Yersinia enterocolitica and related species from the faeces of cows. J Appl Bacteriol (1983) 0.94

Overexpression of Lon contributes to survival and aggressive phenotype of cancer cells through mitochondrial complex I-mediated generation of reactive oxygen species. Cell Death Dis (2013) 0.94

ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survival. Br J Cancer (2011) 0.92